Nature Communications (Oct 2021)
SARS-CoV-2 vaccine breakthrough infections with the alpha variant are asymptomatic or mildly symptomatic among health care workers
- Francesca Rovida,
- Irene Cassaniti,
- Stefania Paolucci,
- Elena Percivalle,
- Antonella Sarasini,
- Antonio Piralla,
- Federica Giardina,
- Josè Camilla Sammartino,
- Alessandro Ferrari,
- Federica Bergami,
- Alba Muzzi,
- Viola Novelli,
- Alessandro Meloni,
- Sara Cutti,
- Anna Maria Grugnetti,
- Giuseppina Grugnetti,
- Claudia Rona,
- Marinella Daglio,
- Carlo Marena,
- Antonio Triarico,
- Daniele Lilleri,
- Fausto Baldanti
Affiliations
- Francesca Rovida
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- Irene Cassaniti
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- Stefania Paolucci
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- Elena Percivalle
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- Antonella Sarasini
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- Antonio Piralla
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- Federica Giardina
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- Josè Camilla Sammartino
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- Alessandro Ferrari
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- Federica Bergami
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- Alba Muzzi
- Medical Direction, Fondazione IRCCS Policlinico San Matteo
- Viola Novelli
- Medical Direction, Fondazione IRCCS Policlinico San Matteo
- Alessandro Meloni
- Medical Direction, Fondazione IRCCS Policlinico San Matteo
- Sara Cutti
- Medical Direction, Fondazione IRCCS Policlinico San Matteo
- Anna Maria Grugnetti
- Health Professions Direction, Fondazione IRCCS Policlinico San Matteo
- Giuseppina Grugnetti
- Health Professions Direction, Fondazione IRCCS Policlinico San Matteo
- Claudia Rona
- Medical Direction, Fondazione IRCCS Policlinico San Matteo
- Marinella Daglio
- Medical Direction, Fondazione IRCCS Policlinico San Matteo
- Carlo Marena
- Medical Direction, Fondazione IRCCS Policlinico San Matteo
- Antonio Triarico
- Direzione Sanitaria, Fondazione IRCCS Policlinico San Matteo
- Daniele Lilleri
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- Fausto Baldanti
- Molecular Virology Unit, Microbiology and Virology Department, Fondazione IRCCS Policlinico San Matteo
- DOI
- https://doi.org/10.1038/s41467-021-26154-6
- Journal volume & issue
-
Vol. 12,
no. 1
pp. 1 – 7
Abstract
Several COVID-19 vaccines have shown good efficacy in clinical trials. Here, the authors provide real world effectiveness data in a group of BNT162b2 vaccinated health care workers and find that breakthrough infections are asymptomatic or mild.
